Similarly, VX765, a potent caspase-1 inhibitor, decreases the truncation of alpha-synuclein into its highly aggregation-prone form, playing a neuroprotective role in a neuronal cell model of PD [105]. This evidence concerns the gene SNCA and Parkinson disease.